Sarcoma

Top Story

Stress and cancer: Mindfulness is pivotal component to improve outcomes

August 24, 2015

Stress hormones are released when the body responds to physical, mental or emotional pressures.

These stress hormones — such as epinephrine and norepinephrine — increase blood pressure, heart rate and blood glucose levels.

William Tap In the Journals

Novel agent shows promise in treatment of rare joint neoplasm

August 18, 2015
PLX3397, a selective CSF1R inhibitor, demonstrated safety and activity in the treatment of patients with tenosynovial giant-cell tumor, according to study findings…
Diana W. Bianchi, MD In the Journals

False-positive NIPT results may be due to presence of maternal malignancies

August 7, 2015
Occult maternal malignancies may provide a biological explanation for some discordant non-invasive prenatal test results.Many professional societies recommend…
FDA News

FDA grants orphan drug designation to dactinomycin formulation for Ewing's sarcoma

July 30, 2015
The FDA granted orphan drug designation to a formulation of dactinomycin for the treatment of children with Ewing’s sarcoma, according to a press release from the…
CME
Hematology Oncology Case Consults

The Patient with Chronic Lymphocytic Leukemia

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with chronic lymphocytic leukemia.
More »
Tailored Therapies for Myelodysplastic Syndromes

Tailored Therapies for Myelodysplastic Syndromes

This activity is supported by an educational grant from Celgene Corporation.

Myelodysplastic syndromes (MDS) represent a group of myeloid clonal hemopathies with heterogeneous clinical…
More »
Lorenzo Cohen, PhD

Stress and cancer: Mindfulness is pivotal component to improve outcomes

August 24, 2015
Stress hormones are released when the body responds to physical, mental or emotional pressures.These stress hormones — such as epinephrine and…
William Tap In the Journals

Novel agent shows promise in treatment of rare joint neoplasm

August 18, 2015
PLX3397, a selective CSF1R inhibitor, demonstrated safety and activity in the treatment of patients with tenosynovial giant-cell tumor, according to…
Diana W. Bianchi, MD In the Journals

False-positive NIPT results may be due to presence of maternal malignancies

August 7, 2015
Occult maternal malignancies may provide a biological explanation for some discordant non-invasive prenatal test results.Many professional societies…
FDA News

FDA grants orphan drug designation to dactinomycin formulation for Ewing's sarcoma

July 30, 2015
The FDA granted orphan drug designation to a formulation of dactinomycin for the treatment of children with Ewing’s sarcoma, according to a…
In the Journals

Pegylated interferon alfa-2b provides minimal benefit as maintenance therapy for osteosarcoma

June 25, 2015
The addition of pegylated interferon alfa-2b maintenance therapy to chemotherapy with methotrexate, doxorubicin and cisplatin did not statistically…
Emily L. Mueller, MD Meeting News Coverage

Pediatric soft tissue sarcoma survivors at risk for chronic medical conditions

June 16, 2015
CHICAGO — Long-term survivors of pediatric soft tissue sarcoma were at a nearly fourfold higher risk for chronic medical conditions compared…
Drug PipelinePerspectivePublication Exclusive

2015 Oncology Drugs in the Pipeline

HemOnc Today, May 25, 2015
HemOnc Today’s annual Oncology Drugs in the Pipeline chart lists agents in phase 2 or phase 3 development for a variety of indications. Clinicians…
Perspective

Eribulin improves survival for patients with advanced liposarcoma, leiomyosarcoma

May 31, 2015
 CHICAGO – The chemotherapy drug eribulin conferred a 2-month median OS improvement in previously treated patients with advanced…
FDA News

FDA grants orphan drug designation to Triolimus for angiosarcoma

April 29, 2015
The FDA granted orphan drug designation to Triolimus for the treatment of patients with angiosarcoma, according to a press release from the…
In the Journals

Long-term treatment with trabectedin extends PFS, OS in soft tissue sarcoma

March 13, 2015
Patients with soft tissue sarcoma who received trabectedin until disease progression demonstrated significantly improved PFS and OS compared with…
More Headlines »
morganatic-roan
morganatic-roan